Immune System Key - Crunchbase Company Profile & Funding

Overview

Immune System Key

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Immune System Key

CB Rank

2398876

ISK is dedicated to discovering and developing innovative treatments for malignant and autoimmune diseases.

Founded

obfuscation

Private

Jerusalem, Yerushalayim, Israel

1-10

www.immunesk.com

Key People

Yoram Devary: Co-Founder and CTO

Details

Also Known As

ISK

Operating Status

Active

Company Type

For Profit

Founders

Yoram Devary

About the Company

ISK is dedicated to discovering and developing innovative treatments for malignant and autoimmune diseases. The company was established in 2005 by two scientists, Professor Uziel Sandler and Dr. Yoram Devary.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Nerofe

Nerofe is a peptide-based drug candidate designed to treat malignant and autoimmune diseases by inhibiting tumor growth, activating immune response, and blocking angiogenesis.

Novel Human Secreted Peptides (Other than Nerofe)

ISK is developing additional peptides derived from natural human proteins with potential anti-cancer and immune-regenerative properties.